ScholarLens Back to search
2008•Medical Journal of Chinese People's HealthRequires access

Comparative analysis between ziprasidone and risperidone in teratment of schizophrenia

Meijuan Wang

Open publisher page 0 citations

Abstract

Objective:To explore the efficacy and safety of ziprasidone in treatment of schizophrenia.Methods:60 patients with schizophreia were randomly assigned two groups ziprasidone group(n=30) and respenridone group(n=30) for 8 week.Positive and negative syndrome scale(PANSS) and treatment side effect scale(TESS)were used to evaluate the efficacy and side effects respectively.Results: The response rate and marked response rate was 83.3% and70.0% in ziprasidone treatment patients,and which was 86.7% and 73.3% in risperidone randomly patients.Conclusions: Ziprasidone has better treatment efficacy and less adverse effects in schizophrenia.

About this research paper

What this paper is about

Objective:To explore the efficacy and safety of ziprasidone in treatment of schizophrenia.Methods:60 patients with schizophreia were randomly assigned two groups ziprasidone group(n=30) and respenridone group(n=30) for 8 week.Positive and negative syndrome scale(PANSS) and treatment side effect scale(TESS)were used to evaluate the efficacy and side effects respectively.Results: The response rate and marked response rate was 83.3% and70.0% in ziprasidone treatment patients,and which was 86.7% and 73.3% in risperidone randomly patients.Conclusions: Ziprasidone has better treatment efficacy and less adverse effects in schizophrenia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the efficacy and safety of ziprasidone in treatment of schizophrenia.Methods:60 patients with schizophreia were randomly assigned two groups ziprasidone group(n=30) and respenridone group(n=30) for 8 week.Positive and negative syndrome scale(PANSS) and treatment side effect scale(TESS)were used to evaluate the efficacy and side effects respectively.Results: The response rate and marked response rate was 83.3% and70.0% in ziprasidone treatment patients,and which was 86.7% and 73.3% in risperidone randomly patients.Conclusions: Ziprasidone has better treatment efficacy and less adverse effects in schizophrenia.

Key concepts: Ziprasidone, Risperidone, Positive and Negative Syndrome Scale, Schizophrenia (object-oriented programming), Internal medicine, Medicine, Adverse effect, Side effect (computer science)

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Comparative analysis between ziprasidone and risperidone in teratment of schizophrenia — Research Paper | ScholarLens